Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Malignant hyperthermia: a pharmacogenetic disorder.

Pharmacogenomics - 1 Nov 2008

Stowell Kathryn M

Abstract excerpt

Malignant hyperthermia (MH) is a pharmacogenetic disorder triggered by volatile anesthetics or depolarizing muscle relaxants in predisposed individuals. Exercise or stress-induced MH episodes, in the absence of any obvious pharmacological trigger, have been reported, but these are rare. A considerable effort has taken place over the last two decades to identify mutations associated with MH and characterize their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium
Share to Genetic Predisposition to Disease
Share to Malignant Hyperthermia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle, Skeletal

Share to Myocardium

Share to Pharmacogenetics

Share to Ryanodine Receptor Calcium Release Channel

Source

Identifiers

PMID: 19018722
DOI: 10.2217/14622416.9.11.1657

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Malignant hyperthermia: a pharmacogenetic disorder.PMID 19018722Read ↗

Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.Semantic proximity Read ↗

Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.Semantic proximity Read ↗

Considerations for diverse RYR1 variants in malignant hyperthermia susceptible patients: a report of two cases.Semantic proximity Read ↗

Functional characterization of RYR1 variants identified in malignant hyperthermia susceptible individuals.Semantic proximity Read ↗

Genetics and pathogenesis of malignant hyperthermiaSemantic proximity Read ↗

Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation.Semantic proximity Read ↗

Malignant hyperthermia and associated disorders.Semantic proximity Read ↗

Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.Semantic proximity Read ↗

Malignant hyperthermia.Semantic proximity Read ↗

Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.Semantic proximity Read ↗

Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility.Semantic proximity Read ↗

Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.